These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32327529)

  • 1. Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain.
    Eiselt É; Otis V; Belleville K; Yang G; Larocque A; Régina A; Demeule M; Sarret P; Gendron L
    J Pharmacol Exp Ther; 2020 Jul; 374(1):52-61. PubMed ID: 32327529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio.
    Eiselt E; Côté J; Longpré JM; Blais V; Sarret P; Gendron L
    Eur J Pharmacol; 2019 Apr; 848():80-87. PubMed ID: 30707956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine metabolites.
    Christrup LL
    Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved brain uptake and pharmacological activity profile of morphine-6-glucuronide using a peptide vector-mediated strategy.
    Temsamani J; Bonnafous C; Rousselle C; Fraisse Y; Clair P; Granier LA; Rees AR; Kaczorek M; Scherrmann JM
    J Pharmacol Exp Ther; 2005 May; 313(2):712-9. PubMed ID: 15647327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of analogues of M6G.
    Trécant C; Dlubala A; George P; Pichat P; Ripoche I; Troin Y
    Eur J Med Chem; 2011 Sep; 46(9):4035-41. PubMed ID: 21689868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
    Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
    Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-linear blood-brain barrier transport and dosing strategies influence receptor occupancy ratios of morphine and its metabolites in pain matrix.
    Budda D; Gülave B; van Hasselt JGC; de Lange ECM
    Br J Pharmacol; 2024 Oct; 181(20):3856-3868. PubMed ID: 38663441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?
    Faura CC; Olaso JM; Cabanes CG; Horga JF
    Pain; 1996 Apr; 65(1):25-30. PubMed ID: 8826486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine metabolism, transport and brain disposition.
    De Gregori S; De Gregori M; Ranzani GN; Allegri M; Minella C; Regazzi M
    Metab Brain Dis; 2012 Mar; 27(1):1-5. PubMed ID: 22193538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 12-oxochenodeoxycholate on the pharmacokinetics and pharmacodynamics of morphine 6-glucuronide in Wistar rats.
    Yang L; Fawcett JP; Zhang H; Tucker IG
    J Pharm Pharmacol; 2013 Apr; 65(4):561-6. PubMed ID: 23488785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine-6-glucuronide: an analgesic of the future?
    Lötsch J; Geisslinger G
    Clin Pharmacokinet; 2001; 40(7):485-99. PubMed ID: 11510626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers.
    Murthy BR; Pollack GM; Brouwer KL
    J Clin Pharmacol; 2002 May; 42(5):569-76. PubMed ID: 12017351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.
    Bouw MR; Xie R; Tunblad K; Hammarlund-Udenaes M
    Br J Pharmacol; 2001 Dec; 134(8):1796-804. PubMed ID: 11739257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences.
    Romberg R; Olofsen E; Sarton E; den Hartigh J; Taschner PE; Dahan A
    Anesthesiology; 2004 Jan; 100(1):120-33. PubMed ID: 14695733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.
    Doyle HH; Murphy AZ
    Physiol Behav; 2018 Apr; 187():32-41. PubMed ID: 29199028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children.
    Verscheijden LFM; Litjens CHC; Koenderink JB; Mathijssen RHJ; Verbeek MM; de Wildt SN; Russel FGM
    PLoS Comput Biol; 2021 Mar; 17(3):e1008786. PubMed ID: 33661919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine.
    Wu D; Kang YS; Bickel U; Pardridge WM
    Drug Metab Dispos; 1997 Jun; 25(6):768-71. PubMed ID: 9193881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.
    Klimas R; Mikus G
    Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
    Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML
    Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of morphine-6-glucuronide (M6G) for postoperative pain relief: a randomized, double-blind study.
    Smith TW; Binning AR; Dahan A
    Eur J Pain; 2009 Mar; 13(3):293-9. PubMed ID: 18550399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.